More features – Page 18
-
FeatureThe chemistry of the yellow jersey
Hayley Bennett tells the story of the 1948 Tour de France’s yellow jersey – and how synthetic fabrics came to dominate sportswear
-
FeatureScience's problem with unconscious bias
Kit Chapman looks at how people are tackling the hidden biases holding sections of society back in pursuing a career in science
-
FeatureA slice of ion beam–scanning microscopy
From brain cells to batteries, is there anything focused ion beam–scanning electron microscopy can’t study?
-
FeatureAccess to drugs: a failure of pharma?
Many people around the world are either unable to afford the drugs they need, or their conditions have not been addressed by pharma R&D. Sarah Houlton investigates
-
FeatureDelivering gene therapy
After some well-publicised problems, gene therapy – delivering DNA into people’s cells using viruses – is booming, Anthony King finds
-
Feature200 years of Gmelin’s handbook
2017 marks 200 years since Leopold Gmelin first published his influential handbook – and it’s still going strong, as Mike Sutton discovers
-
FeatureRaiders of the lost pigments
The old sculptures in museums have lost their original colour, but chemistry can help us discover how they used to look
-
FeatureSpinning out spider silk research
Spider silk is finding applications as diverse as tissue transplants and training shoes
-
FeatureWearable technology
The future of wearable gadgets will be tiny, flexible, skin-like devices capable of monitoring your health
-
-
FeatureCovalent inhibitor drugs
Exceptions to a long-held rule against chemically bonding to biological targets are powering new cancer medicines, finds Andy Extance
-
FeatureThe flow revolution
Continuous approaches are starting to find use in fine chemicals, as Angeli Mehta discovers
-
-
FeatureMOFs find a use
Nina Notman takes stock of the first products containing metal–organic frameworks to hit the shelves
-
FeatureSmartphone recycling
Although smartphones contain a host of valuable metals, getting at them is the tricky bit. Emma Davies reports
-
FeatureAntidepressant pollution
What are the consequences of medicating wildlife against anxiety and depression? Ida Emilie Steinmark reports
-
FeatureHow ketamine could help treat severe depression
Nina Notman looks at how the party drug ketamine may hold the key to treating patients with severe depression
-
FeatureThe chemist with x-ray vision
Mike Sutton tells the tale of John Kendrew and his work on the structure of myoglobin
-
FeatureDeal or no deal?
Clare Sansom highlights recent changes in the landscape of pharma company collaborations and acquisitions
-
FeatureShedding light on the dark proteome
Around half of all human proteins are a mystery. What do they look like, asks Phil Ball